BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15366323)

  • 1. Monitoring methotrexate therapy in patients with rheumatoid arthritis.
    Wiela-Hojenska A; Orzechowska-Juzwenko K; Swierkot J; Wiland P; Hurkacz M; Szechinski J
    Int J Clin Pharmacol Ther; 2004 Aug; 42(8):434-41. PubMed ID: 15366323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of correlation between pharmacokinetics and efficacy of low dose methotrexate in patients with rheumatoid arthritis.
    Lafforgue P; Monjanel-Mouterde S; Durand A; Catalin J; Acquaviva PC
    J Rheumatol; 1995 May; 22(5):844-9. PubMed ID: 8587070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse effects of low dose methotrexate in rheumatoid arthritis patients.
    Gilani ST; Khan DA; Khan FA; Ahmed M
    J Coll Physicians Surg Pak; 2012 Feb; 22(2):101-4. PubMed ID: 22313647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Splitting high-dose oral methotrexate improves bioavailability: a pharmacokinetic study in patients with rheumatoid arthritis.
    Hoekstra M; Haagsma C; Neef C; Proost J; Knuif A; van de Laar M
    J Rheumatol; 2006 Mar; 33(3):481-5. PubMed ID: 16463431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal measurement of methotrexate liver concentrations does not correlate with liver damage, clinical efficacy, or toxicity during a 3.5 year double blind study in rheumatoid arthritis.
    Fathi NH; Mitros F; Hoffman J; Straniero N; Labreque D; Koehnke R; Furst DE
    J Rheumatol; 2002 Oct; 29(10):2092-8. PubMed ID: 12375317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of methotrexate and sulphasalazine in patients with rheumatoid arthritis: pharmacokinetic analysis and relationship to clinical response.
    Haagsma CJ; Russel FG; Vree TB; Van Riel PL; Van de Putte LB
    Br J Clin Pharmacol; 1996 Aug; 42(2):195-200. PubMed ID: 8864317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Renal tubular dysfunction in patients with rheumatoid arthritis starting with low dose of methotrexate].
    Wiland P; Wiela-Hojeńska A; Swierkot J; Hurkacz M; Orzechowska-Juzwenko K; Szechiński J
    Pol Arch Med Wewn; 2003 Aug; 110(2):855-62. PubMed ID: 14682224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, parallel, single-site pilot trial to compare two different starting doses of methotrexate in methotrexate-naïve adult patients with rheumatoid arthritis.
    Hobl EL; Mader RM; Jilma B; Duhm B; Mustak M; Bröll H; Högger P; Erlacher L
    Clin Ther; 2012 May; 34(5):1195-203. PubMed ID: 22516039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with rheumatoid arthritis treated with methotrexate (MTX): concentrations of steady-state erythrocyte MTX correlate to plasma concentrations and clinical efficacy.
    Hornung N; Ellingsen T; Attermann J; Stengaard-Pedersen K; Poulsen JH
    J Rheumatol; 2008 Sep; 35(9):1709-15. PubMed ID: 18634162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total and free methotrexate pharmacokinetics in rheumatoid arthritis patients.
    Edno L; Bressolle F; Gomeni R; Bologna C; Sany J; Combe B
    Ther Drug Monit; 1996 Apr; 18(2):128-34. PubMed ID: 8721274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of methotrexate on the gene expression of the pro-inflammatory cytokine IL-12A in the therapy of rheumatoid arthritis.
    Hobl EL; Mader RM; Erlacher L; Duhm B; Mustak M; Bröll H; Högger P; Kalipciyan M; Jilma B
    Clin Exp Rheumatol; 2011; 29(6):963-9. PubMed ID: 22133036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate therapy is not associated with increased liver stiffness and significant liver fibrosis in rheumatoid arthritis patients: A cross-sectional controlled study with real-time two-dimensional shear wave elastography.
    Erre GL; Cadoni ML; Meloni P; Castagna F; Mangoni AA; Piga M; Passiu G; Carru C; Zinellu A; Vidili G
    Eur J Intern Med; 2019 Nov; 69():57-63. PubMed ID: 31474422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate-treated patients with rheumatoid arthritis.
    Lie E; van der Heijde D; Uhlig T; Heiberg MS; Koldingsnes W; Rødevand E; Kaufmann C; Mikkelsen K; Kvien TK
    Ann Rheum Dis; 2010 Apr; 69(4):671-6. PubMed ID: 19740904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate pharmacogenetics in rheumatoid arthritis.
    Brinker RR; Ranganathan P
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S33-9. PubMed ID: 21044431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A short-chain methotrexate polyglutamate as outcome parameter in rheumatoid arthritis patients receiving methotrexate.
    Hobl EL; Jilma B; Erlacher L; Duhm B; Mustak M; Bröll H; Högger P; Rizovski B; Mader RM
    Clin Exp Rheumatol; 2012; 30(2):156-63. PubMed ID: 22152098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate pharmacokinetic is influenced by co-administration of cyclosporin in rheumatoid arthritis patients. Results from a randomized clinical trial.
    Odderskov C; Stengaard-Pedersen K; Ellingsen T; Hornung N
    Scand J Clin Lab Invest; 2020 May; 80(3):185-190. PubMed ID: 31876200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between methotrexate pharmacokinetic parameters, and clinical and biological status in rheumatoid arthritis patients.
    Bologna C; Anaya JM; Bressolle F; Jorgensen C; Alric R; Sany J
    Clin Exp Rheumatol; 1995; 13(4):465-70. PubMed ID: 7586778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness, tolerability, and safety of subcutaneous methotrexate in early rheumatoid arthritis: A retrospective analysis of real-world data from the St. Gallen cohort.
    Müller RB; von Kempis J; Haile SR; Schiff MH
    Semin Arthritis Rheum; 2015 Aug; 45(1):28-34. PubMed ID: 25895697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Side effects of methotrexate therapy for rheumatoid arthritis: A systematic review.
    Wang W; Zhou H; Liu L
    Eur J Med Chem; 2018 Oct; 158():502-516. PubMed ID: 30243154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update on methotrexate.
    Braun J; Rau R
    Curr Opin Rheumatol; 2009 May; 21(3):216-23. PubMed ID: 19373092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.